NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 98 filers reported holding NATERA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,164 | -17.0% | 26,304 | -8.8% | 0.10% | -28.6% |
| Q2 2023 | $1,403 | +47.2% | 28,842 | +68.1% | 0.14% | +48.9% |
| Q1 2023 | $953 | -99.6% | 17,161 | +562.3% | 0.09% | +213.3% |
| Q4 2021 | $242,000 | -79.8% | 2,591 | -92.7% | 0.03% | -78.4% |
| Q4 2019 | $1,196,000 | +107.6% | 35,489 | +102.1% | 0.14% | +78.2% |
| Q3 2019 | $576,000 | +53.6% | 17,564 | +29.3% | 0.08% | +85.7% |
| Q2 2019 | $375,000 | +20.2% | 13,586 | +4.3% | 0.04% | +147.1% |
| Q3 2018 | $312,000 | +157.9% | 13,022 | +26.1% | 0.02% | +142.9% |
| Q4 2016 | $121,000 | – | 10,324 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |